Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Sales (2020 - 2025)

Historic Return on Sales for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to 1.47%.

  • Rapid Micro Biosystems' Return on Sales rose 200.0% to 1.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.45%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 1.67% for FY2024, which is 6600.0% up from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Return on Sales stood at 1.47%, which was up 200.0% from 1.63% recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year Return on Sales high stood at 1.18% for Q4 2024, and its period low was 4.42% during Q1 2021.
  • Its 5-year average for Return on Sales is 2.53%, with a median of 2.37% in 2024.
  • As far as peak fluctuations go, Rapid Micro Biosystems' Return on Sales plummeted by -20100bps in 2021, and later soared by 20000bps in 2023.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Return on Sales stood at 2.8% in 2021, then plummeted by -34bps to 3.76% in 2022, then skyrocketed by 53bps to 1.76% in 2023, then soared by 33bps to 1.18% in 2024, then dropped by -25bps to 1.47% in 2025.
  • Its Return on Sales stands at 1.47% for Q3 2025, versus 1.63% for Q2 2025 and 1.56% for Q1 2025.